Searchable abstracts of presentations at key conferences in endocrinology

ea0077oc2.5 | Endocrine Cancer and Late Effects | SFEBES2021

A novel MiR-346-Directed DNA damage mechanism is regulated by its interaction with long non-coding RNA, NORAD, in prostate cancer

Fletcher Claire , Orafidiya Folake , Deng Lin , Yuan Wei , Lorentzen Marc , Cyran Oliwia , Varela-Carver Anabel , Constantin Theodora , Dobbs Felix , Figueiredo Ines , Gurel Bora , Parkes Eileen , Bogdan Denisa , Pereira Ronnie , Zhao Shuang (George) , Neeb Antje , Issa Fadi , Hester Joanna , Kudo Hiromi , Liu Yang , Philippou Yiannis , Bristow Robert , Knudsen Karen , Bryant Richard , Feng Felix , Reed Simon , Mills Ian , de Bono Johann , Bevan Charlotte

MiR-346 is an Androgen Receptor (AR)-activating miR that associates with DNA damage response (DDR)-linked transcripts in prostate cancer (PC). MiR-346 induces rapid and extensive DNA damage in PC cells through chromatin association, activation of transcription, R-loop formation and DNA replication stress, leading to checkpoint activation and cell cycle arrest. MiR-346 interacts with lncRNA, NORAD, in PC cells, which functions to maintain mitosis, DDR, and chromosomal integrity...

ea0014p313 | (1) | ECE2007

Fas and FasL expression on peripheral lymphocytes in patients with autoimmune thyroid disease

Fountoulakis Stelios , Vartholomatis George , Philippou George , Tsatsoulis Agathocles

Objective: The Fas/Fas ligand (FasL) apoptotic pathway is activated in patients with autoimmune thyroid disease (AITD). It is believed that Fas and FasL expression in intrathyroidal T lymphocytes and thyrocytes is regulated in a manner resulting in thyroid cell apoptosis in Hashimoto’s thyroiditis (HT) or lymphocyte apoptosis in Graves’ disease (GD). The hypothesis that Fas and FasL may be differentially expressed on peripheral lymphocytes in patients with HT and GD ...

ea0011p842 | Thyroid | ECE2006

Differential regulation of soluble Fas in patients with autoimmune thyroid disease

Fountoulakis S , Kolaitis N , Philippou G , Vartholomatos G , Tsatsoulis A

Introduction-objective: Fas-mediated thyroid cell apoptosis is differentially regulated in autoimmune thyroid disease (AITD) being up-regulated in Hashimoto’s thyroiditis (HT) and down-regulated in Graves’ disease (GD). The soluble form of Fas (sFas), lacking the transmembrane domain due to alternative splicing may inhibit apoptosis by binding to Fas ligand. In this preliminary study we examined whether sFas is also differentially expressed in patients with AITD....

ea0036P66 | (1) | BSPED2014

Growth characteristics in children with Temple syndrome: an under-diagnosed imprinting disorder

Lokulo-Sodipe Kemi , Ioannides Yiannis , Davies Justin H , Karen Temple I

Background: Temple syndrome (TS) is a disorder caused by dysregulation of imprinted genes at chromosome 14q32. It is important to distinguish the growth pattern from other imprinting disorders such as Russell–Silver and Prader–Willi syndromes.Aims: To describe the growth pattern in TS.Methods: 51 cases were identified from 11 countries. Height, weight, birth weight and head circumference were converted to SDS using countr...

ea0035p1080 | Thyroid (non-cancer) | ECE2014

Associations of thyroid function and autoantibodies with parameters of oxidative stress in women with Hashimoto's thyroiditis

Giannakou Maria , Saltiki Katerina , Loukari Eleni , Mantzou Emily , Philippou George , Terzidis Konstantinos , Stavrianos Charalampos , Alevizaki Maria

Objectives: Patients with thyroid dysfunction due to AITD have been found to have increased oxidative stress. Possible associations of oxidative stress with thyroid hormone (TH) and thyroid autoantibodies (ThAb) levels in euthyroid patients with autoimmune thyroiditis have not been adequately studied. We examined possible associations of oxidative stress markers with TH levels and with the presence of ThAb in euthyroid women with Hashimoto’s thyroiditis (with or without T...

ea0029p555 | Diabetes | ICEECE2012

Does the presence of thyroid antibodies affect the course and outcome of pregnancy in type1 diabetic women?

Sarantopoulou V , Philippou G , Vasileiou V , Lymberi P , Sarika L , Alevizaki M , Anastasiou E

Introduction: In the literature there are only three papers so far, addressing the impact of thyroid antibodies (Anti-TPO) on pregnancy in Type1 Diabetic Women (DM1) and these present conflicting results. The aim of the study is to evaluate the presence of Anti-TPO in DM1 pregnant women and whether these are related with differences in thyroid function, metabolic control and pregnancy outcome.Methods: In 78 DM1 women with singleton pregnancies Anti-TPO, ...

ea0073pep5.6 | Presented ePosters 5: Thyroid | ECE2021

Is the igf-1ec isoform a novel biomarker for advanced differentiated thyroid cancer?

Karagiannis Apostolos , Philippou Anastassios , Sofia Tseleni-Balafouta , Zebolis Evaggelos , Nakouti Theodora , Koutsilieris Michael

BackgroundRecent knowledge implicates a differential expression of the insulin-like growth factor-1 (IGF-1) mRNA splice variants (i.e., IGF-1Ea, IGF-1Eb and IGF-1Ec) in cancerous tissues, implying possible specific roles of the encoded IGF-1 protein isoforms in cancer biology. In particular, there is growing evidence that IGF-1Ec isoform may plays a distinct biological role in various types of cancer. The aim of the present study was to investigate wheth...

ea0099rc4.5 | Rapid Communications 4: Diabetes, Obesity, Metabolism and Nutrition | Part I | ECE2024

Precision medicine in type 2 diabetes mellitus: Unraveling the role of TCF7L2, CTRB1/2, and GLP-1R genetic variants in response to treatment with glucagon-like peptide-1 receptor agonists

Kyriakidou Artemis , Kyriazou Angeliki , Koufakis Theocharis , Vasilopoulos Yiannis , Avramidis Iakovos , Baltagiannis Stefanos , Goulis Dimitrios , Zebekakis Pantelis , Kotsa Kalliopi

Background and Aims: Our objective was to assess the association between genetic polymorphisms in TCF7L2, CTRB1/2 and GLP-1R genes and inter-individual variability in response to treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in terms of glycemic control and weight loss among Greek individuals with type 2 diabetes mellitus (T2DM) and to identify potential predictors of response to GLP-1 RA therapy.Material...

ea0041ep633 | Endocrine tumours and neoplasia | ECE2016

Mechano growth factor (MGF) expression increased in secondary compared to primary foci in well neuroendocrine neoplasms

Alexandraki Krystallenia , Philippou Anastasios , Boutzios Georgios , Moschouris Panagiotis , Karnezis James , Theohari Irini , Koutsilieris Michael , Delladetsima Ioanna , Kaltsas Gregory

Introduction: Insulin-like growth factor-I (IGF-I) has a role in cell proliferation, differentiation, migration, and survival. By alternative splicing different IGF-I mRNA transcripts as IGF-IEc (mechano growth factor, MGF) or IGF-IEa variants are produced. MGF induces muscle hypertrophy and implicated in the pathophysiology of various types of cancer. Aim of the study was to investigate the role of MGF in the pathophysiology of neuroendocrine neoplasms (NENs).<p class="ab...

ea0041ep973 | Thyroid (non-cancer) | ECE2016

Autoimmune thyroiditis: association with two common polymorphisms of the RAGE gene and oxidative stress

Giannakou Maria , Saltiki Katerina , Mantzou Emily , Loukari Eleni , Philippou Georgios , Terzidis Konstantinos , Lilly Kiriaki , Stavrianos Charalampos , Alevizaki Maria

Introduction: Polymorphisms of the receptor for advanced glycation end products (AGEs), RAGE, have been associated with autoimmune disorders and their complications. There are no studies concerning Hashimoto’s thyroiditis (HT); the aim of our study was to investigate the possible role of two RAGE polymorphisms (−429T>C, −374T>A) in combination with indices of oxidative status in women with HT.Design: We examined 300 euth...